Kawasaki disease: management
Evidence-based neurology checklist on kawasaki disease: management: Laboratory features Leukocytosis Anaemia Raised erythrocyte sedimentation rate (ESR) Raised C-reactive protein (CRP) Increased platelet count Increased transaminases Low serum protein (hypoalbulinaemia) Reduced plasma cholesterol…
Laboratory features
- Leukocytosis
- Anaemia
- Raised erythrocyte sedimentation rate (ESR)
- Raised C-reactive protein (CRP)
- Increased platelet count
- Increased transaminases
- Low serum protein (hypoalbulinaemia)
- Reduced plasma cholesterol
- Reduced high-density lipoprotein (HDL)
- Reduced apolipoprotein A-I
Cerebrospinal fluid (CSF) analysis
Other investigations
Acute treatment: Aspirin
Acute treatment: intravenous immunoglobulins (IVIg)
Treatment of refractory disease: adjunctive options
Treatment of severe disease: anti-thrombotic options
Synonym
Acronym
References
- Rowley AH, Shulman ST. Recent advances in the understanding and management of Kawasaki disease. Curr Infect Dis Rep 2010; 12:96-102.
- Kim DS. Kawasaki disease. Yonsei Med J 2006; 47:759-772.
- Rowley AH, Shulman ST. Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther 2010; 8:197-203.
- Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child 2014; 99:74-83.
- Melish ME. Kawasaki syndrome (the mucocutaneous lymph node syndrome). Annu Rev Med 1982; 33:569-585.
- And 0 more. Subscribe to see the full list
